Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients

BACKGROUND: Hyperphosphatemia necessitates the use of phosphate binders in most dialysis patients. Long-term efficacy and tolerability of the iron-based phosphate binder, sucroferric oxyhydroxide (previously known as PA21), was compared with that of sevelamer carbonate (sevelamer) in an open-label P...

Full description

Saved in:
Bibliographic Details
Published in:Nephrol Dial Transplant
Main Authors: Floege, Jürgen, Covic, Adrian C., Ketteler, Markus, Mann, Johannes F.E., Rastogi, Anjay, Spinowitz, Bruce, Chong, Edward M.F., Gaillard, Sylvain, Lisk, Laura J., Sprague, Stuart M.
Format: Artigo
Language:Inglês
Published: Oxford University Press 2015
Subjects:
Clinical Science
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4438742/
https://ncbi.nlm.nih.gov/pubmed/25691681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv006
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items